68 results on '"Kobie, James J."'
Search Results
2. SWIFT clustering analysis of intracellular cytokine staining flow cytometry data of the HVTN 105 vaccine trial reveals high frequencies of HIV-specific CD4+ T cell responses and associations with humoral responses
3. Correction for Piepenbrink et al., “Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies”
4. Highly Cross-Reactive and Protective Influenza A Virus H3N2 Hemagglutinin- and Neuraminidase-Specific Human Monoclonal Antibodies
5. Immunization with Recombinant Accessory Protein-Deficient SARS-CoV-2 Protects against Lethal Challenge and Viral Transmission
6. Structure and epitope of a neutralizing monoclonal antibody that targets the stem helix of β coronaviruses
7. Antibodies, B Cell Responses and Immune Responses to SARS-CoV-2 Infections
8. Monitoring SARS-CoV-2 Infection Using a Double Reporter-Expressing Virus
9. Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens
10. Structure and Epitope of a Neutralizing Monoclonal Antibody that Targets the Stem Helix of β Coronaviruses
11. Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
12. Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
13. CD4+ T Cells Are Dispensable for Induction of Broad Heterologous HIV Neutralizing Antibodies in Rhesus Macaques
14. Analysis of SARS-CoV-2 infection dynamic in vivo using reporter-expressing viruses
15. Mixed Origins: HIV gp120-specific memory develops from pre-existing memory and naïve B cells following vaccination in humans
16. Duration of post-COVID-19 symptoms are associated with sustained SARS-CoV-2 specific immune responses
17. Visualization of SARS-CoV-2 infection dynamic
18. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
19. Epitope classification and RBD binding properties of neutralizing antibodies against SARS-CoV-2 variants of concern
20. Generation and Characterization of Recombinant SARS-CoV-2 Expressing Reporter Genes
21. Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
22. Polyfunctional Tier 2–Neutralizing Antibodies Cloned following HIV-1 Env Macaque Immunization Mirror Native Antibodies in a Human Donor
23. Generation and Characterization of recombinant SARS-CoV-2 expressing reporter genes
24. Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
25. Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature
26. Persistence of HIV-1 Env-Specific Plasmablast Lineages in Plasma Cells after Vaccination in Humans
27. Cloning and functional testing of rhesus macaque ( Macaca mulatta ) IL‐9 and IL‐33
28. A Broad and Potent H1-Specific Human Monoclonal Antibody Produced in Plants Prevents Influenza Virus Infection and Transmission in Guinea Pigs
29. A broad and potent H1-specific human monoclonal antibody produced in plants prevents influenza virus infection and transmission in guinea pigs
30. Identification of variant HIV envelope proteins with enhanced affinities for precursors to anti-gp41 broadly neutralizing antibodies
31. Broad and Protective Influenza B Virus Neuraminidase Antibodies in Humans after Vaccination and their Clonal Persistence as Plasma Cells
32. IL-33 enhances the kinetics and quality of the antibody response to a DNA and protein-based HIV-1 Env vaccine
33. Display of the HIV envelope protein at the yeast cell surface for immunogen development
34. A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody
35. Effect of Tumor Derived TGF-Beta on the Efficacy of Dendritic Cell Vaccines
36. Effect of Tumor Derived TGF-Beta on the Efficacy of Dendritic Cell Vaccines
37. Curaxin CBL0100 Blocks HIV-1 Replication and Reactivation through Inhibition of Viral Transcriptional Elongation
38. A Novel Bromodomain Inhibitor Reverses HIV-1 Latency through Specific Binding with BRD4 to Promote Tat and P-TEFb Association
39. Pre-existing neutralizing antibody mitigates B cell dysregulation and enhances the Env-specific antibody response in SHIV-infected rhesus macaques
40. Increased Steady-State Memory B Cell Subsets Among High-Risk Participants in an HIV Vaccine Trial
41. Humoral Dysregulation Associated with Increased Systemic Inflammation among Injection Heroin Users
42. Platelet Activation in Human Immunodeficiency Virus Type-1 Patients Is Not Altered with Cocaine Abuse
43. Functional and Molecular Characteristics of Novel and Conserved Cross-Clade HIV Envelope Specific Human Monoclonal Antibodies
44. Cutting Edge: An Antibody Recognizing Ancestral Endogenous Virus Glycoproteins Mediates Antibody-Dependent Cellular Cytotoxicity on HIV-1–Infected Cells
45. Transient decrease in human peripheral blood myeloid dendritic cells following influenza vaccination correlates with induction of serum antibody
46. Microbubble array diffusion assay for the detection of cell secreted factors
47. 9G4+ Antibodies Isolated from HIV-Infected Patients Neutralize HIV-1 and Have Distinct Autoreactivity Profiles
48. Characterization of cell seeding and specific capture of B cells in microbubble well arrays
49. Anti-idiotypic monobodies for immune response profiling
50. 9G4 Autoreactivity Is Increased in HIV-Infected Patients and Correlates with HIV Broadly Neutralizing Serum Activity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.